Effect of surgical volume and hospital type on outcome in non-small cell lung cancer surgery: A Finnish population-based study

Lung Cancer

Volumn 59, Issue 1, 2008, Pages 119-125

  Sioris, Thanos ^a   Sihvo, Eero ^b   Sankila, Risto ^c   Salo, Jarmo ^b  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c FINNISH CANCER REGISTRY   (Finland)

Author keywords

Hospital mortality; Hospital type; Hospital volume; Long term survival; Non small cell lung cancer; Surgery

Indexed keywords

ADULT; ARTICLE; CANCER REGISTRY; CANCER SURGERY; FEMALE; FINLAND; FOLLOW UP; HOSPITALIZATION; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; OUTCOMES RESEARCH; OVERALL SURVIVAL; POPULATION RESEARCH; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PRIVATE HOSPITAL; SURVIVAL TIME; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HOSPITAL MORTALITY; HOSPITALS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PULMONARY SURGICAL PROCEDURES;

EID: 37549028362     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2007.07.020     Document Type: Article

References (25)

1. Birim O., Kappetein A.P., van Klaveren R.J., and Bogers A.J. Prognostic factors in non-small cell lung cancer surgery. Eur J Surg Oncol 32 (2006) 12-23
2. Begg C.B., Cramer L.D., Hoskins W.J., and Brennan M.F. Impact of hospital volume on operative mortality for major cancer surgery. JAMA 280 (1998) 1747-1751
3. Birkmeyer J.D., Siewers A.E., Finlayson E.V., Stukel T.A., Lucas F.L., Batista I., et al. Hospital volume and surgical mortality in the United States. N Engl J Med 346 (2002) 1128-1137
4. Finlayson E.V., and Birkmeyer J.D. Effects of hospital volume on life expectancy after selected cancer operations in older adults: a decision analysis. J Am Coll Surg 196 (2003) 410-417
5. Finlayson E.V., Goodney P.P., and Birkmeyer J.D. Hospital volume and operative mortality in cancer surgery: a national study. Arch Surg 138 (2003) 721-725
6. Hillner B.E., Smith T.J., and Desch C.E. Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer care. J Clin Oncol 18 (2000) 2327-2340
7. Bach P.B., Cramer L.D., Schrag D., Downey R.J., Gelfand S.E., and Begg C.B. The influence of hospital volume on survival after resection for lung cancer. N Engl J Med 345 (2001) 181-188
8. Treasure T., Utley M., and Bailey A. Assessment of whether in-hospital mortality for lobectomy is a useful standard for the quality of lung cancer surgery: retrospective study. BMJ 327 (2003) 73
9. Freixinet J.L., Julia-Serda G., Rodriguez P.M., Santana N.B., de Castro F.R., Fiuza M.D., et al. Hospital volume: operative morbidity, mortality and survival in thoracotomy for lung cancer. A Spanish multicenter study of 2994 cases. Eur J Cardiothorac Surg 29 (2006) 20-25
10. Ginsberg R.J. Lung cancer surgery: acceptable morbidity and mortality, expected results and quality control. Surg Oncol 11 (2002) 263-266
11. Handy Jr. J.R., Asaph J.W., Skokan L., Reed C.E., Koh S., Brooks G., et al. What happens to patients undergoing lung cancer surgery? Outcomes and quality of life before and after surgery. Chest 122 (2002) 21-30
12. Graham A.N., Chan K.J., Pastorino U., and Goldstraw P. Systematic nodal dissection in the intrathoracic staging of patients with non-small cell lung cancer. J Thorac Cardiovasc Surg 117 (1999) 246-251
13. Chatkin J.M., Abreu C.M., Fritscher C.C., Wagner M.B., and Pinto J.A. Is there a gender difference in non-small cell lung cancer survival?. Gend Med 1 (2004) 41-47
14. Ries L.A. Influence of extent of disease, histology, and demographic factors on lung cancer survival in the SEER population-based data. Semin Surg Oncol 10 (1994) 21-30
15. Tammemagi C.M., Neslund-Dudas C., Simoff M., and Kvale P. Smoking and lung cancer survival: the role of comorbidity and treatment. Chest 125 (2004) 27-37
16. Liberman M., Liberman D., Sampalis J.S., and Mulder D.S. Delays to surgery in non-small-cell lung cancer. Can J Surg 49 (2006) 31-36
17. Birim O., Maat A.P., Kappetein A.P., van Meerbeeck J.P., Damhuis R.A., and Bogers A.J. Validation of the Charlson comorbidity index in patients with operated primary non-small cell lung cancer. Eur J Cardiothorac Surg 23 (2003) 30-34
18. Treasure T. The surgeon is only one factor. BMJ 324 (2002) 421
19. Silvestri G.A., Handy J., Lackland D., Corley E., and Reed C.E. Specialists achieve better outcomes than generalists for lung cancer surgery. Chest 114 (1998) 675-680
20. Gagarine A., Urschel J.D., Miller J.D., Bennett W.F., and Young J.E. Preoperative and intraoperative factors predictive of length of hospital stay after pulmonary lobectomy. Ann Thorac Cardiovasc Surg 9 (2003) 222-225
21. Toh C.K., Gao F., Lim W.T., Leong S.S., Fong K.W., Yap S.P., et al. Never-smokers with lung cancer: epidemiologic evidence of a distinct disease entity. J Clin Oncol 24 (2006) 2245-2251
22. Mountain C.F. The international system for staging lung cancer. Semin Surg Oncol 18 (2000) 106-115
23. Farrow D.C., Hunt W.C., and Samet J.M. Biased comparisons of lung cancer survival across geographic areas: effects of stage bias. Epidemiology 6 (1995) 558-560
24. Chirikos T.N. Appraising the economic efficiency of cancer treatment: an exploratory analysis of lung cancer. Health Care Manage Sci 6 (2003) 87-95
25. Posther K.E., and Harpole Jr. D.H. The surgical management of lung cancer. Cancer Invest 24 (2006) 56-67